Advance new therapies
Stay human

BiomimX unlocks in vitro models reflecting human complexity, towards the design of effective treatments tailored for patients.

Beating Organs-on-Chip are the next generation of pre-clinical models: human, dynamic, 3D.

BiomimX unlocks in vitro models reflecting human complexity, towards the design of effective treatments tailored for patients.
Beating Organs-on-Chip are the next generation of pre-clinical models:
human, dynamic, 3D.

Advance new therapies
Stay human

Discover the therapies of tomorrow
by catching human data today

Every tissue in the body is subjected to motion.

Our Beating Organs-on-Chip finally bring this motion into the 3D native microenvironment, offering clinically relevant human in vitro setups.

Every tissue in the body is subjected to motion.

Our Beating Organs-on-Chip finally bring this motion into the 3D native microenvironment, offering clinically relevant human in vitro setups.

Discover our Services

Test Your Compounds in Human Relevant in vitro Models

Boost Your Pipeline

BiomimX provides services to enhance every step of your pipeline by relying on native-like data from uBeat®-powered models.

Partner with us and leverage on BiomimX®’s expertise and strong scientific know-how, to get your product profiled.

Get inspired by our Applications

Safety - Toxicology

Predict safety and toxicity of therapeutic candidates in human models.

Efficacy in Diseases

Predict therapeutic candidates’ efficacy in human models of diseases.

Advanced Therapies

Predict the toxicity and efficacy of gene, antibody and cell therapeutics in human models.

Microbiome interaction

Elucidate gastrointestinal microbiome interaction at patient specific level.

Discover our Products

Develop Your in vitro Physiological & Pathological Models

uBeat® Platform & uBoX Pro

The uBeat® Setup supports the culture of 3D microtissue models within the  uBeat® Platform.

The patented uBeat® Technology allows to provide a controlled mechanical stimulation to the microtissues through the uBoX Pro.

The mechanical stimulation will drive the model development, mimicking the native human tissues.

Get inspired by our uBeat®-powered models

uHeart

homepage_ubeat_tissue
uHeartSymbol_nowaves_website

A functional beating human Heart-on-a-Chip with real time electrical activity recording functionality.

uKnee

uknee
uKneeSymbol_nowaves_website

The first in vitro miniaturized models of human healthy and osteoarthritic Cartilage-on-Chip.

uGut

uGut_webpage_cover
uGut_Symbol_nowaves_Website

A human model of the gastrointestinal tract, with intestinal epithelium and endothelium.

uScar

uScar_webpage_cover
uScar_nowaves_website

A miniaturized human model recapitulating the key traits of cardiac fibrosis.

Learn more about our
Biological Models and Scientific Expertise

From our high-ranked publications on peer-reviewed journals

An Advanced Mechanically Active Osteoarthritis-on-Chip Model to Test Injectable Therapeutic Formulations: The SYN321 Case Study

Advanced Healthcare Materials
Sep 2024

In Vitro Mechanical Stimulation to Reproduce the Pathological Hallmarks of Human Cardiac Fibrosis on a Beating Chip and Predict The Efficacy of Drugs and Advanced Therapies

Advanced Healthcare Materials
Nov 2023

LivHeart: A Multi Organ-on-Chip Platform to Study Off-Target Cardiotoxicity of Drugs Upon Liver Metabolism

Advanced Materials Technologies
Jan 2023

Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform

Toxicological Sciences
Oct 2022

Read all Publications

Meet us

February 11-13 2025

Join our Commercial Science Leader, Dr. Erika Ferrari and our Business Developer Victoria Rabsiun at the WORD+ 2025 in Cambridge, UK.

stay tuned BiomimX

Latest News

PHOENIX Kickoff

Cooperation, sharing and synergy, three key-words that marked the beginning of PHOENIX project, funded under the Horizon Europe programme (HORIZON-HLTH-2024-TOOL-05-two-stage) and coordinated by Prof. Marco Rasponi from the Department of Electronics Information and Bioengineering of Politecnico di Milano.

PHOENIX aims to revolutionize biomedical research by developing advanced Organs-on-Chip (OoC) platforms that will foster the investigation of complex pathologies, focusing on cardiac and neuro-muscular diseases. Such platforms will enhance our understanding of disease mechanisms, accelerating drug discovery and ultimately leading to reduced animal testing.

On February 3-4, 2025, the kick-off meeting brought together the partners of the project, nine organizations coming from various parts of Europe, each of them bringing diverse background and expertise to the table. Milestones were set, the roadmap was outlined, now the project is ready to start. Stay tuned!

LinkedIn
BiomimX @ WORD+
📢 Meet us at @WORD+2025 in Cambridge!

As proud sponsors of WORD+2025, BiomimX will be exhibiting at booth #1 on February 11-12 near Cambridge, UK. Join our Commercial Science Leader, Dr. Erika Ferrari, and Business Developer Victoria Rabsiun to discover how our uBeat®-powered in vitro models are transforming preclinical research and boosting pharmaceutical pipelines, by replicating key physio-pathological features of human organs.

📍 Don’t miss the opportunity to connect with us—see you at WORD+!

Event
Biofit 2024
📢 Meet us at Biofit 2024 next week!

As member of Mabdesign, BiomimX will attend Biofit that will take place from the 2nd to the 5th December in Lille, France.

You will have the opportunity to meet our CEO, Dr. Paola Occhetta and our Commercial Science Leader, Dr. Erika Ferrari to discover how our uBeat®-Powered in vitro models are revolutionizing pre-clinical research and boost pharmaceutical pipelines, recapitulating the key physio-pathological features of human organs.

Also, don’t miss our Pitch that will be presented on the 4th of December!

Event website
Queen Mary University of London Facilities

We are incredibly proud to announce that Queen Mary University of London recently acquired different in vitro model facilities for educational purposes and BiomimX uBeat® setup, is one of them!

These facilities have been funded through a mixture of commercial partnerships, internal funding, research project grants and a large infrastructure grant from the NC3Rs and BBSRC. The facilities are integrated with category II cell culture, advanced microscopy and molecular biology and biochemistry facilities.

Learn more